Predictors of death or transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO Registry
L. Snyder (Durham, North Carolina, United States of America), M. Neely (Durham, North Carolina, United States of America), A. Hellkamp (Durham, North Carolina, United States of America), E. O'Brien (Durham, North Carolina, United States of America), K. Flaherty (Ann Arbor, Michigan, United States of America), J. De Andrade (Birmingham, Alabama, United States of America), C. Conoscenti (Ridgefield, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), S. Bender (Ridgefield, Connecticut, United States of America), M. Gulati (New Haven, Connecticut, United States of America), D. Culver (Cleveland, Ohio, United States of America), R. Kaner (New York, New York, United States of America), S. Palmer (Durham, North Carolina, United States of America), H. Kim (Minneapolis, Minnesota, United States of America)
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Snyder (Durham, North Carolina, United States of America), M. Neely (Durham, North Carolina, United States of America), A. Hellkamp (Durham, North Carolina, United States of America), E. O'Brien (Durham, North Carolina, United States of America), K. Flaherty (Ann Arbor, Michigan, United States of America), J. De Andrade (Birmingham, Alabama, United States of America), C. Conoscenti (Ridgefield, Connecticut, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), S. Bender (Ridgefield, Connecticut, United States of America), M. Gulati (New Haven, Connecticut, United States of America), D. Culver (Cleveland, Ohio, United States of America), R. Kaner (New York, New York, United States of America), S. Palmer (Durham, North Carolina, United States of America), H. Kim (Minneapolis, Minnesota, United States of America). Predictors of death or transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO Registry. 2196
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: